Acorda Therapeutics, RSS Feed | Nachrichten | finanzen.netwww.finanzen.net bietet Finanznachrichten zum weltweiten Boersengeschehenhttp://www.finanzen.netde-deSmartHouse Media GmbHhttp://finanzen.net/images/finanzen_net.gifFinanzen.nethttp://www.finanzen.netAcorda Therapeutics Presents Additional Data from Second Positive Phase 3 Study of Fampridine-SR at World Congress on Treatment and Research in Multiple Sclerosishttp://www.finanzen.net/nachricht/Acorda_Therapeutics_Presents_Additional_Data_from_Second_Positive_Phase_3_Study_of_Fampridine_SR_at_World_Congress_on_Treatment_and_Research_in_Multiple_Sclerosis_782701 <style type="text/css"> <!-- .bwlistitemmarginbottom {margin-bottom: 10.0px} .bwtextaligncenter {text-align: center} --> </style> Acorda Therapeutics, Inc. (NASDAQ: ACOR) today announced additional data from its second Phase 3 clinical ...http://www.finanzen.net/nachricht/Acorda_Therapeutics_Presents_Additional_Data_from_Second_Positive_Phase_3_Study_of_Fampridine_SR_at_World_Congress_on_Treatment_and_Research_in_Multiple_Sclerosis_782701Acorda Therapeutics to Present at the UBS Global Life Sciences Conferencehttp://www.finanzen.net/nachricht/Acorda_Therapeutics_to_Present_at_the_UBS_Global_Life_Sciences_Conference_780552 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} --> </style> Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that Ron Cohen, M.D., President CEO, will present a corporate overview at the upcoming ...http://www.finanzen.net/nachricht/Acorda_Therapeutics_to_Present_at_the_UBS_Global_Life_Sciences_Conference_780552Acorda Therapeutics To Present Phase 3 Fampridine-SR Data at World Congress on Treatment and Research in Multiple Sclerosis Meetinghttp://www.finanzen.net/nachricht/Acorda_Therapeutics_To_Present_Phase_3_Fampridine_SR_Data_at_World_Congress_on_Treatment_and_Research_in_Multiple_Sclerosis_Meeting_779198 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} --> </style> Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that data from its recently-completed Fampridine-SR Phase 3 trial (MS-F204) will be ...http://www.finanzen.net/nachricht/Acorda_Therapeutics_To_Present_Phase_3_Fampridine_SR_Data_at_World_Congress_on_Treatment_and_Research_in_Multiple_Sclerosis_Meeting_779198Acorda Therapeutics to Present at the Baird's 2008 Small Cap Health Care Conferencehttp://www.finanzen.net/nachricht/Acorda_Therapeutics_to_Present_at_the_Baird_s_2008_Small_Cap_Health_Care_Conference_775863 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} --> </style> Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that Tierney Saccavino, Vice President of Corporate Communications, will present a ...http://www.finanzen.net/nachricht/Acorda_Therapeutics_to_Present_at_the_Baird_s_2008_Small_Cap_Health_Care_Conference_775863Acorda Therapeutics to Present at the 3rd Annual Citi Biotech Day Conferencehttp://www.finanzen.net/nachricht/Acorda_Therapeutics_to_Present_at_the_3rd_Annual_Citi_Biotech_Day_Conference_775667 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} --> </style> Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that Ron Cohen, M.D., President CEO, will present a corporate overview at the upcoming ...http://www.finanzen.net/nachricht/Acorda_Therapeutics_to_Present_at_the_3rd_Annual_Citi_Biotech_Day_Conference_775667Acorda Therapeutics, Inc. Announces Exercise of Option by Underwriterhttp://www.finanzen.net/nachricht/Acorda_Therapeutics_Inc_Announces_Exercise_of_Option_by_Underwriter_774753 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} --> </style> Acorda Therapeutics, Inc. (NASDAQ: ACOR) (the <span id="bwanpa2">"Company<span id="bwanpa3">”) announced today that Deutsche Bank Securities Inc., ...http://www.finanzen.net/nachricht/Acorda_Therapeutics_Inc_Announces_Exercise_of_Option_by_Underwriter_774753Acorda Therapeutics Reports Second Quarter 2008 Financial Resultshttp://www.finanzen.net/nachricht/Acorda_Therapeutics_Reports_Second_Quarter_2008_Financial_Results_763906Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced its financial results for the second quarter of 2008. "Acorda continued to achieve important milestones in this quarter,” said Ron Cohen, M.D., Acorda Therapeutics’ President ...http://www.finanzen.net/nachricht/Acorda_Therapeutics_Reports_Second_Quarter_2008_Financial_Results_763906Acorda Therapeutics to Present at the Bank of America 2008 Specialty Pharmaceuticals Conferencehttp://www.finanzen.net/nachricht/Acorda_Therapeutics_to_Present_at_the_Bank_of_America_2008_Specialty_Pharmaceuticals_Conference_763572Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that Ron Cohen, M.D., President & CEO, will present a corporate overview at the upcoming Bank of America 2008 Specialty Pharmaceuticals Conference on Friday, August 08, 2008 ...http://www.finanzen.net/nachricht/Acorda_Therapeutics_to_Present_at_the_Bank_of_America_2008_Specialty_Pharmaceuticals_Conference_763572Acorda Therapeutics Presents Positive Data from Preclinical Studies of Neuregulins in Cardiac Functionhttp://www.finanzen.net/nachricht/Acorda_Therapeutics_Presents_Positive_Data_from_Preclinical_Studies_of_Neuregulins_in_Cardiac_Function_760947Acorda Therapeutics, Inc. (Nasdaq: ACOR) presented data on the company’s neuregulin molecule GGF2 demonstrating improved cardiac function in preclinical models of heart failure. The data also indicated that GGF2 provided more benefit ...http://www.finanzen.net/nachricht/Acorda_Therapeutics_Presents_Positive_Data_from_Preclinical_Studies_of_Neuregulins_in_Cardiac_Function_760947Acorda Therapeutics to Host Conference Call to Report Second Quarter 2008 Financial Results on August 5, 2008http://www.finanzen.net/nachricht/Acorda_Therapeutics_to_Host_Conference_Call_to_Report_Second_Quarter_2008_Financial_Results_on_August_5_2008_760099Acorda Therapeutics, Inc. (NASDAQ: ACOR) announced today that it will report its financial results for the second quarter of 2008 on Tuesday, August 5, 2008 at 8:30 a.m. ET before the U.S. financial markets open. In conjunction ...http://www.finanzen.net/nachricht/Acorda_Therapeutics_to_Host_Conference_Call_to_Report_Second_Quarter_2008_Financial_Results_on_August_5_2008_760099